Primary Cells Market Size is valued at USD 1.63 Bn in 2022 and is predicted to reach USD 3.91 Bn by the year 2031 at a 10.4% CAGR during the forecast period for 2023-2031.
Primary cells are cells isolated from a living organism as opposed to "cell lines," which have been grown for a long time and are frequently employed in various biological and medical research purposes. Because they more closely resemble cells in living organisms and provide a more precise depiction of cell behaviour, operation, and responses to stimuli than immortalized cell lines, human primary cells are in high demand by research institutes and pharmaceutical companies for developing potential cancer medicines and treatments.
In addition, Growth in the pharmaceutical and biotechnology sectors, rising demand for monoclonal antibodies, increasing government investments in cell-based research, and growing interest in cancer treatment are all factors driving the expansion of this market. More in-depth studies using primary cells by researchers and drug development companies have become possible thanks to developments in automation, single-cell analysis, and imaging technologies, and these developments, along with infrastructure improvements, are expected to stoke the market's Growth over the next few years.
However, the market expansion may be hampered by the scarcity of particular cell types and fresh samples due to cell source restrictions and a short lifespan in culture. In addition, the primary cell market benefited from COVID-19. Researchers study the infection and develop standardized epithelial cell culture models using primary cell culture. These models can help replicate the characteristics of the respiratory system, which could lead to important medical discoveries.
Furthermore, there has been a rise in the isolation of primary cells for treating various illnesses. Private organizations, biotech firms, and government bodies have all increased their focus and funding on these technologies as they find more and more uses in healthcare. Primary cell cultures are becoming increasingly popular for viral synthesis, which is utilized to produce a wide variety of vaccines.
Competitive Landscape
Some Major Key Players In The Primary Cells Market:
- Thermo Fisher Scientific, Inc.
- Merck KgAa
- Corning Incorporated
- Lonza Group
- Charles River Laboratories, Inc.
- PromoCell Gmbh
- American Type Culture Collection (ATCC)
- Cell Biologics, Inc.
- Zen-Bio, Inc.
- Stemcell Technologies, Inc.
- AllCells
- iXCells Biotechnologies
- Neuromics
- Axol Bioscience Ltd.
- StemExpress
- Bioivt
- ScienCell Research Laboratories, Inc.
- AMSBIO
- ProMab Biotechnologies, Inc.
- Creative Bioarray
- Bps Bioscience, Inc.
- Epithelix
- Reachbio Research Labs
- AcceGen
- Kosheeka
- Others
Market Segmentation:
The primary cells market is segmented based on type, origin and end-user. Based on type, the market is segmented into hematopoietic, dermatocytes, hepatocytes, gastrointestinal, lung, renal, heart, and musculoskeletal. By origin, the market is segmented into human primary cells and animal primary cells. By end user, the market is segmented into life science research companies, research institutes, and others.
Based On The Type, The Hematopoietic Primary Cells Market Segment Is Accounted As A Major Contributor To The Primary Cells Market.
The hematopoietic primary cells category is expected to hold a major global market share due to the rising prevalence of blood malignancies and other immune system illnesses, as well as factors such as the use of Hematopoietic cell transplants and the research and development of novel cancer medicines. The largest projected growth rate is anticipated for hepatocytes because of their rising demand in toxicological and pharmacological research.
Human Primary Cells Segment To Witness Growth At A Rapid Rate.
The human primary cells segment is projected to grow rapidly in the global Primary Cells market. Human primary cells have been used extensively in cancer cell research and toxicity. Demand for reliable disease models, progress in research and drug discovery, the emergence of regenerative medicine, the need for rigorous safety testing, the growing prevalence of chronic diseases, technological advances, ethical considerations, and scientific collaborations are all factors propelling the human market forward, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North America Primary Cells Market Holds A Significant Revenue Share.
The North America primary cells market activity is anticipated to record the largest market share in revenue in the near future. It can be attributed to because of the high price of healthcare, the growing number of elderly, the increasing incidence of chronic diseases, and the money provided by the government.
Furthermore, growing interest in gene therapy, the availability of new research tools, and the expansion of the field all contribute to the size of the market in the United States. In addition, Asia Pacific is projected to grow rapidly in the global primary cells market due to the industry's focus on developing innovative applications for cultivating cells, improving its instruments, expanding its repertoire of cell kinds, and studying the intercellular interactions between them.
Recent Developments:
- In March 2023, Thermo Fisher Scientific established a cell therapy facility at the (UCSF) to expedite the advancement of innovative therapeutic interventions. The anticipated collaboration between Thermo Fisher and UCSF in 2021 presented an opportunity to explore the hypothesis that the proximity of scientists, doctors, and patients to a manufacturing facility could enhance the efficiency of breakthrough drug development.
- In Aug 2023, The recent announcement by the business indicates that the Phase III LITESPARK-005 research demonstrated that Merck's Welireg (belzutifan) successfully achieved its primary objective of a significant enhancement in progression-free survival for patients diagnosed with advanced renal cell carcinoma.
Primary Cells Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 1.63 Bn |
|
Revenue Forecast In 2031 |
USD 3.91 Bn |
|
Growth Rate CAGR |
CAGR of 10.4 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Origin, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Inc., Merck Kgaa, Corning Incorporated, Lonza Group, Charles River Laboratories, Inc., Promocell Gmbh, American Type Culture Collection (ATCC), Cell Biologics, Inc., Zenbio, Inc., Stemcell Technologies, Inc., Allcells, Ixcells Biotechnologies, Neuromics, Axol Bioscience Ltd., Stemexpress, Bioivt, Sciencell Research Laboratories, Inc., Amsbio, Promab Biotechnologies, Inc., Creative Bioarray, Bps Bioscience, Inc., Epithelix, Reachbio Research Labs, Accegen, Kosheeka and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
